KRO-06038

rac-norlaudanosine; tetrahydropapaverine; norlaudanosine

13074-31-2
98% min.
scale-up (10-1,000 kg)
C20H25NO4

KRO-04965

3-chloroacetyl-2-(2-chloro-ethylamino)-[1,3,2]oxazaphosphinane (R)-2-oxide; IFOSFAMIDEACYLATE; (R)-2-Chloro-1-(2-((2-chloroethyl)amino)-2-oxido-1,3,2-oxazaphosphinan-3-yl)ethanone; 3-(2-CHLOROACETYL)-2-[(2-CHLOROETHYL)AMINO]TETRAHYDRO-2H-1,3,2-OXAZAPHOSPHORINE-2-OXIDE; IfofaMide acylation objects

72578-71-3
98% min.
scale-up (10-1,000 kg)
C7H13Cl2N2O3P

KRO-04966

Isophosphamide; ilfosfamide; iphosphamide; rac-iphosphamide; ifosphamide; 3-(2-Chloroethyl)-2-[(2-chloroethyl)amino]tetrahydro-2H-1,3,2-oxazaphosphorine 2-oxide; 3-(2-chloroethyl)-2-[(2-chloroethyl)-amino]-2-oxo-1,3,2-oxazaphosphorinane; Ifex N,3-Bis(2-chloroethyl)tetrahydro-2H-1,3,2-oxazaphosphorin-2-amine-2-oxide

3778-73-2
98% min.
scale-up (10-1,000 kg)
C7H15Cl2N2O2P

KRO-17576

7-Chloro-1,2,3,4-tetrahydro-5H-1-benzazepin-5-one; 7-CHLORO-1,2,3,4-TETRAHYDRO-BENZO[B]AZEPIN-5-ONE; 7-Chloro-3,4-dihydro-1H-benzo[b]azepin-5(2H)-one; 7-Chloro-1,2,3,4-tetrahydrobenzo[b]azepin-5-one

160129-45-3
98% min.
scale-up (10-1,000 kg)
C10H10ClNO

KRO-02728

CI-1025; Conivaptanhydrochloride; Vaprisol; Conivaptan hydrochloride [USAN]; Conivaptan HCl; N-[4-(2-methyl-4,5-dihydro-3H-imidazo[4,5-d][1]benzazepine-6-carbonyl)phenyl]-2-phenylbenzamide,hydrochloride; YM-087; (1,1''-Biphenyl)-2-carboxamide,N-(4-((4,5-dihydro-2-methylimidazo(4,5-d)(1)benzazepin-6(1H)-yl)carbonyl)phenyl)-,monohydrochloride; UNII-75L57R6X36

168626-94-6
98% min.
scale-up (10-1,000 kg)
C32H27ClN4O2

KRO-36157

2-methyl-1,4,5,6-tetrahydroimidazo(4,5-d)(1)benzazepine

318237-73-9
98% min.
scale-up (10-1,000 kg)
C12H13N3

KRO-01286

(+/-)-5-dimethylamino-1-[4-(2-methylbenzoylamino)-benzoyl]-2,3,4,5-tetrahydro-1H-benzazepin; N-(4-((5-(Dimethylamino)-2,3,4,5-tetrahydro-1H-1-benzazepin-1-yl)carbonyl)phenyl)-2-methylbenzamide; Mozavaptan; Mozavaptan [INN]; Benzamide,N-(4-((5-(dimethylamino)-2,3,4,5-tetrahydro-1H-1-benzazepin-1-yl)carbonyl)phenyl)-2-methyl; 5-dimethylamino-1-[4-[(2-methylbenzoyl)amino]benzoyl]-2,3,4,5-tetrahydro-1H-benzazepine; N-(4-(((5RS)-5-(Dimethylamino)-2,3,4,5-tetrahydro-1H-1-benzazepin-1-yl)carbonyl)phenyl)-2-methylbenzamide

137975-06-5
98% min.
scale-up (10-1,000 kg)
C27H29N3O2

KRO-07551

Lixivaptan; UNII-8F5X4B082E; WAY-VPA-985; VPA-985

168079-32-1
98% min.
scale-up (10-1,000 kg)
C27H21ClFN3O2

KRO-00786

(3R)-3-cyclopentyl-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)pyrazol-1-yl]propionitrile; Ruxolitinib; ((3R)-3-cyclopentyl-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)pyrazol-1-yl]propanenitrile); (R)-3-(4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-cyclopentylpropanenitrile

941678-49-5
98% min.
scale-up (10-1,000 kg)
C17H18N6

KRO-02697

Besifloxacin HCl

405165-61-9
98% min.
scale-up (10-1,000 kg)
C19H22Cl2FN3O3

KRO-17159

8-chloro-1,2,3,4-tetrahydro-1-benzazepin-5-one

116815-03-3
98% min.
scale-up (10-1,000 kg)
C10H10ClNO

KRO-45155

2-[(trifluoro)ethoxy]phenol; 2,6-DIFLUORO-3-METHYLPHENYLACETIC ACID; 2-(2,2,2-trifluoroethoxy) phenol

160968-99-0
98% min.
scale-up (10-1,000 kg)
C8H7F3O2

KRO-44987

1-(2-Bromoethoxy)-2-(2,2,2-trifluoroethoxy)benzene; 1-(2-bromoethoxy)-2-(2,2,2-trifluoroethoxy)benzene

160969-00-6
98% min.
scale-up (10-1,000 kg)
C10H10BrF3O2

KRO-44597

aka latrepiridine; Preparation 84; Dimebolin; Dimeboline; Dimebon; Latrepirdine; Dimebone

3613-73-8
98% min.
scale-up (10-1,000 kg)
C21H25N3

KRO-41870

1H-Pyrido(4,3-b)indole,2,3,4,5-tetrahydro-2,8-dimethyl; DEHYDROSTOBADINE; 2,3,4,5-Tetrahydro-2,8-dimethyl-1H-pyrido(4,3-b)indole; 2,8-Dimethyl-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indole; 2.8-dimethyl-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indole; 2,5-DIOXOPYRROLIDIN-1-YL 12-SULFANYLDODECANOATE

19686-05-6
98% min.
scale-up (10-1,000 kg)
C13H16N2

KRO-46974

(R)-trans-1,2-Bis-hydroxymethyl-cyclohexan; (R,R)-(-)-pseudoephedrine glycinamide hydrate; (1R,2R)-(-)-pseudoephedrine glycinamide; 1,2-bis(hydroxymethyl)cyclohexane; (R)-trans-1,2-bis-hydroxymethyl-cyclohexane; (+)-(1R,2R)-trans-1,2-bis(hydroxymethyl)cyclohexane; trans-2-hydroxymethylcyclohexylmethanol; 2-amino-N-((1R,2R)-1-hydroxy-1-phenylpropan-2-yl)-N-methylacetamide; pseudoephedrine glycinamide; (R,R)-1,2-bis(hydroxymethyl)cyclohexane; (1R,2R)-(-)-trans-cyclohexane-1,2-diyldimethanol; (1R,2R)-1,2-Cyclohexanedimethanol; (-)-pseudoephedrine glycinamide monohydrate

65376-05-8
98% min.
scale-up (10-1,000 kg)
C8H16O2

KRO-46840

(1S,2S)-Cyclohexane-1,2-dimethanol; (1S,2S)-1,2-CYCLOHEXANEDIMETHANOL; 1S,2S,(-)]-1,2-CYCLOHEXANEDIMETHANOL; (1S,2S)-Cyclohexane-1,2-diyldimethanol

3205-34-3
98% min.
scale-up (10-1,000 kg)
C8H16O2

KRO-46975

(1R,2R)-1,2-Cyclohexanedicarboxylic Acid; (1R,2R)-(-)-1,2-CYCLOHEXANEDICARBOXYLIC ACID; (1R,2R)-Cyclohexane-1,2-dicarboxylic acid

46022-05-3
98% min.
scale-up (10-1,000 kg)
C8H12O4

KRO-46841

(1S,2S)-1,2-Cyclohexanedicarboxylic Acid; 1,2-trans-cyclohexane-dicarboxylic acid; (1S,2S)-Cyclohexane-1,2-dicarboxylic acid; trans-cyclohexane-1,2-dicarboxylic acid

21963-41-7
98% min.
scale-up (10-1,000 kg)
C8H12O4

KRO-46977

(R,R)-1,2-Bis(Methanesulphonyloxymethyl)cyclohexane; (R)-trans-1,2-bis-methanesulfonyloxymethyl-cyclohexane; (R,R)-1,2-Bis(methanesulfonyloxymethyl)cyclohexane; (1R,2R)-(-)-trans-cyclohexane-1,2-diylbis(methylene)dimethanesulfonate; (1R,2R)-cyclohexane-1,2-diyldimethanediyl dimethanesulfonate; trans-1,2-(1R,2R)-bis(methanesulfonyloxymethyl)cyclohexane; methanesulfonic acid 2-methanesulfonyloxymethyl-cyclohexylmethyl ester; trans-(R,R)-1,2-bis(methanesulfonylmethyl)cyclohexane; (R)-trans-1,2-Bis-methansulfonyloxymethyl-cyclohexan

186204-35-3
98% min.
scale-up (10-1,000 kg)
C10H20O6S2